Home > Boards > US Listed > Biotechs > Opko Health Inc (OPK)

"Based on 4 analysts offering 12 month price

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
JDUB Member Profile
 
Followed By 43
Posts 8,721
Boards Moderated 1
Alias Born 12/07/03
160x600 placeholder
Sian Capital Sends Letter to OPKO Health Regarding its Decision to Apparently Withhold Rayaldee From Many Patients Amidst COV... GlobeNewswire Inc. - 11/20/2020 4:45:00 PM
Sian Capital Issues Open Letter to Stockholders of OPKO Health GlobeNewswire Inc. - 11/12/2020 6:30:00 PM
OPKO Health to Participate in Three Upcoming Investment Conferences GlobeNewswire Inc. - 11/11/2020 9:10:51 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/2/2020 6:57:26 AM
Sian Capital Highlights Paths to Meaningful Value Creation at OPKO Health GlobeNewswire Inc. - 10/29/2020 5:20:36 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 10/29/2020 4:26:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/29/2020 4:08:24 PM
OPKO Health Reports 2020 Third Quarter Business Highlights and Financial Results GlobeNewswire Inc. - 10/29/2020 4:05:10 PM
OPKO Health's BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test PR Newswire (US) - 10/20/2020 8:00:00 AM
OPKO Health to Report Third Quarter 2020 Financial Results on October 29, 2020 GlobeNewswire Inc. - 10/13/2020 12:50:49 PM
OPKO Health's BioReference Laboratories Launches COVID-19 Testing Program for New York City Schools PR Newswire (US) - 10/9/2020 8:00:00 AM
Notice of Class Action Settlement Involving Purchasers of OPKO Health, Inc. Common Stock during the period of September 26, 2... PR Newswire (US) - 10/8/2020 9:08:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/15/2020 10:32:13 AM
OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 Patients GlobeNewswire Inc. - 9/15/2020 7:00:10 AM
TNS New Potential Home Run Report Available Now InvestorsHub NewsWire - 9/3/2020 8:35:00 AM
OPKO Health to Participate in Two September Investment Conferences GlobeNewswire Inc. - 9/2/2020 4:05:10 PM
OPKO Health's BioReference Laboratories Announces New York City Schools COVID-19 Testing Program PR Newswire (US) - 9/2/2020 8:00:00 AM
OPKO Health's BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) Assay PR Newswire (US) - 9/1/2020 3:55:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/27/2020 8:41:29 AM
OPKO Health's GeneDx Enters into Agreement with Pediatrix Medical Group to Offer Neonatal Genomic Services PR Newswire (US) - 8/12/2020 9:15:00 AM
OPKO Health's GeneDx Adds GenomeXpress to Its Industry-Leading Clinical Genomics Portfolio PR Newswire (US) - 8/6/2020 8:00:00 AM
OPKO Health to Participate in BTIG Virtual Biotechnology Conference GlobeNewswire Inc. - 8/5/2020 3:35:52 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 7/31/2020 8:54:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/31/2020 6:28:10 AM
OPKO Health Reports 2020 Second Quarter Business Highlights and Financial Results GlobeNewswire Inc. - 7/30/2020 4:05:10 PM
JDUB   Wednesday, 09/16/20 12:05:20 AM
Re: None
Post # of 13870 
"Based on 4 analysts offering 12 month price targets for Opko Health in the last 3 months. The average price target is $8.00 with a high forecast of $10.00 and a low forecast of $6.50. The average price target represents a 153.97% increase from the last price of $3.15".....Tip Ranks

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences